Krysten Vance1, Alphan Alitinok2, Seth Winfree1,3, Heather Jensen-Smith1, Benjamin J Swanson3, Paul M Grandgenett1, Kelsey A Klute4, Daniel J Crichton2, Michael A Hollingsworth1. 1. Eppley Institute for Research in Cancer and Allied Diseases, Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA. 2. Jet Propulsion Laboratory, California Institute of Technology, Pasadena, CA, USA. 3. Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA. 4. Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
Abstract
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a formidable challenge for patients and clinicians. OBJECTIVE: To analyze the distribution of 31 different markers in tumor and stromal portions of the tumor microenvironment (TME) and identify immune cell populations to better understand how neoplastic, non-malignant structural, and immune cells, diversify the TME and influence PDAC progression. METHODS: Whole slide imaging (WSI) and cyclic multiplexed-immunofluorescence (MxIF) was used to collect 31 different markers over the course of nine distinctive imaging series of human PDAC samples. Image registration and machine learning algorithms were developed to largely automate an imaging analysis pipeline identifying distinct cell types in the TME. RESULTS: A random forest algorithm accurately predicted tumor and stromal-rich areas with 87% accuracy using 31 markers and 77% accuracy using only five markers. Top tumor-predictive markers guided downstream analyses to identify immune populations effectively invading into the tumor, including dendritic cells, CD4+ T cells, and multiple immunoregulatory subtypes. CONCLUSIONS: Immunoprofiling of PDAC to identify differential distribution of immune cells in the TME is critical for understanding disease progression, response and/or resistance to treatment, and the development of new treatment strategies.
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a formidable challenge for patients and clinicians. OBJECTIVE: To analyze the distribution of 31 different markers in tumor and stromal portions of the tumor microenvironment (TME) and identify immune cell populations to better understand how neoplastic, non-malignant structural, and immune cells, diversify the TME and influence PDAC progression. METHODS: Whole slide imaging (WSI) and cyclic multiplexed-immunofluorescence (MxIF) was used to collect 31 different markers over the course of nine distinctive imaging series of human PDAC samples. Image registration and machine learning algorithms were developed to largely automate an imaging analysis pipeline identifying distinct cell types in the TME. RESULTS: A random forest algorithm accurately predicted tumor and stromal-rich areas with 87% accuracy using 31 markers and 77% accuracy using only five markers. Top tumor-predictive markers guided downstream analyses to identify immune populations effectively invading into the tumor, including dendritic cells, CD4+ T cells, and multiple immunoregulatory subtypes. CONCLUSIONS: Immunoprofiling of PDAC to identify differential distribution of immune cells in the TME is critical for understanding disease progression, response and/or resistance to treatment, and the development of new treatment strategies.
Authors: Stéfan van der Walt; Johannes L Schönberger; Juan Nunez-Iglesias; François Boulogne; Joshua D Warner; Neil Yager; Emmanuelle Gouillart; Tony Yu Journal: PeerJ Date: 2014-06-19 Impact factor: 2.984
Authors: Trygve E Bakken; Nikolas L Jorstad; Qiwen Hu; Blue B Lake; Wei Tian; Brian E Kalmbach; Megan Crow; Rebecca D Hodge; Fenna M Krienen; Staci A Sorensen; Jeroen Eggermont; Zizhen Yao; Brian D Aevermann; Andrew I Aldridge; Anna Bartlett; Darren Bertagnolli; Tamara Casper; Rosa G Castanon; Kirsten Crichton; Tanya L Daigle; Rachel Dalley; Nick Dee; Nikolai Dembrow; Dinh Diep; Song-Lin Ding; Weixiu Dong; Rongxin Fang; Stephan Fischer; Melissa Goldman; Jeff Goldy; Lucas T Graybuck; Brian R Herb; Xiaomeng Hou; Jayaram Kancherla; Matthew Kroll; Kanan Lathia; Baldur van Lew; Yang Eric Li; Christine S Liu; Hanqing Liu; Jacinta D Lucero; Anup Mahurkar; Delissa McMillen; Jeremy A Miller; Marmar Moussa; Joseph R Nery; Philip R Nicovich; Sheng-Yong Niu; Joshua Orvis; Julia K Osteen; Scott Owen; Carter R Palmer; Thanh Pham; Nongluk Plongthongkum; Olivier Poirion; Nora M Reed; Christine Rimorin; Angeline Rivkin; William J Romanow; Adriana E Sedeño-Cortés; Kimberly Siletti; Saroja Somasundaram; Josef Sulc; Michael Tieu; Amy Torkelson; Herman Tung; Xinxin Wang; Fangming Xie; Anna Marie Yanny; Renee Zhang; Seth A Ament; M Margarita Behrens; Hector Corrada Bravo; Jerold Chun; Alexander Dobin; Jesse Gillis; Ronna Hertzano; Patrick R Hof; Thomas Höllt; Gregory D Horwitz; C Dirk Keene; Peter V Kharchenko; Andrew L Ko; Boudewijn P Lelieveldt; Chongyuan Luo; Eran A Mukamel; António Pinto-Duarte; Sebastian Preissl; Aviv Regev; Bing Ren; Richard H Scheuermann; Kimberly Smith; William J Spain; Owen R White; Christof Koch; Michael Hawrylycz; Bosiljka Tasic; Evan Z Macosko; Steven A McCarroll; Jonathan T Ting; Hongkui Zeng; Kun Zhang; Guoping Feng; Joseph R Ecker; Sten Linnarsson; Ed S Lein Journal: Nature Date: 2021-10-06 Impact factor: 49.962
Authors: Hartland W Jackson; Jana R Fischer; Vito R T Zanotelli; H Raza Ali; Robert Mechera; Savas D Soysal; Holger Moch; Simone Muenst; Zsuzsanna Varga; Walter P Weber; Bernd Bodenmiller Journal: Nature Date: 2020-01-20 Impact factor: 49.962
Authors: Magdalena Huber; Corinna U Brehm; Thomas M Gress; Malte Buchholz; Bilal Alashkar Alhamwe; Elke Pogge von Strandmann; Emily P Slater; Jörg W Bartsch; Christian Bauer; Matthias Lauth Journal: Int J Mol Sci Date: 2020-10-03 Impact factor: 5.923